Vent Multiplexor and Yale New Haven Hospital announced last week that they received FDA emergency use authorization (EUA) for a ventilator splitter.
The company and hospital collaborated to design the Vent Multiplexor device to offer individualized emergency crisis care for two adult patients in need of mechanical ventilation when limited to just one ventilator machine.
Earlier this month, Yale New Haven Hospital successfully used the device to co-ventilate two critically ill COVID-19 patients with different disease states, lung sizes and tidal volume requirements. The device accurately measured lung compliance of both patients in real-time, according to a news release.
Vent Multiplexor said in the news release that, with the EUA secured, it plans to quickly turn to ramp up production and work with partners across the globe as well.
“Ultimately, we are all part of a global community,” Vent Multiplexor president Todd Higgins said in the release. “The call to action is for all of us to do everything in our power to help wherever that help is needed. We intend to answer the call.”
“Yale New Haven Hospital is proud to have collaborated with Vent Multiplexor LLC and other groups on the development and successful trial of new technologies,” added Yale New Haven Health chief clinical officer & executive VP Dr. Thomas Balcezak. “We are committed to doing everything in our power to bring urgently needed new technologies and treatments to the community in the fight against COVID-19.”